Preclinical Efficacy of Elismetrep, a TRPM8 Blocker, as a Monotherapy and in Combination with Gepants or Triptans Summary As presented at the 2026 American Headache Society annual meeting in June 2026. Content AHS-2026-Elismetrep-MOA-Talk-Non-Conf.pdf ← Back to Resource Library
